Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA589330
Max Phase: Preclinical
Molecular Formula: C21H24ClN3O3
Molecular Weight: 401.89
Molecule Type: Small molecule
Associated Items:
ID: ALA589330
Max Phase: Preclinical
Molecular Formula: C21H24ClN3O3
Molecular Weight: 401.89
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCC(C)[C@H](NC(=O)c1ccc(OC)cc1)C(=O)N/N=C/c1ccc(Cl)cc1
Standard InChI: InChI=1S/C21H24ClN3O3/c1-4-14(2)19(24-20(26)16-7-11-18(28-3)12-8-16)21(27)25-23-13-15-5-9-17(22)10-6-15/h5-14,19H,4H2,1-3H3,(H,24,26)(H,25,27)/b23-13+/t14?,19-/m0/s1
Standard InChI Key: ACAMZSYTMVQLCS-HJKLDDSWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 401.89 | Molecular Weight (Monoisotopic): 401.1506 | AlogP: 3.64 | #Rotatable Bonds: 8 |
Polar Surface Area: 79.79 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 11.66 | CX Basic pKa: 1.40 | CX LogP: 4.21 | CX LogD: 4.21 |
Aromatic Rings: 2 | Heavy Atoms: 28 | QED Weighted: 0.52 | Np Likeness Score: -1.24 |
1. Jin Y, Tan Z, He M, Tian B, Tang S, Hewlett I, Yang M.. (2010) SAR and molecular mechanism study of novel acylhydrazone compounds targeting HIV-1 CA., 18 (6): [PMID:20188575] [10.1016/j.bmc.2010.02.003] |
Source(1):